Model systems duplicating epidermolysis bullosa acquisita: A methodological review

Autoimmunity

Volumn 45, Issue 1, 2012, Pages 102-110

  Ludwig, Ralf J ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Animal model; Autoimmunity; Blister; Epidermolysis bullosa acquisita; Models systems; Skin

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 17; COLLAGEN TYPE 7; IMMUNOGLOBULIN G ANTIBODY;

CHEMOTAXIS; EPIDERMOLYSIS BULLOSA ACQUISITA; EX VIVO STUDY; IMMUNIZATION; IN VITRO STUDY; INCUBATION TIME; LEUKOCYTE ACTIVATION; NONHUMAN; PATHOGENESIS; REVIEW; TISSUE INJURY;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; COLLAGEN TYPE VII; DISEASE MODELS, ANIMAL; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMANS; MICE;

EID: 84856450203     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2011.606451     Document Type: Review

References (35)

1. Chen M, Kim GH, Prakash L, Woodley DT. Epidermolysis bullosa acquisita: Autoimmunity to anchoring fibril collagen. Autoimmunity 2012. Doi 10.3109/08916934.2011.606450.
2. Chiriac MT, Roesler J, Sindrilaru A, Scharffetter-Kochanek K, Zillikens D, Sitaru C. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol 2007;212:56-65. (Pubitemid 46746290)
3. Sitaru C, Kromminga A, Hashimoto T, Brocker EB, Zillikens D. Autoantibodies to type VII collagen mediate Fcgammadependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol 2002; 161:301-311. (Pubitemid 34760796)
4. Sitaru C, Mihai S, Otto C, Chiriac MT, Hausser I, Dotterweich B, Saito H, Rose C, Ishiko A, Zillikens D. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 2005;115:870-878. (Pubitemid 40489391)
5. Sesarman A, Mihai S, Chiriac MT, Olaru F, Sitaru AG, Thurman JM, Zillikens D, Sitaru C. Binding of avian IgY to type VII collagen does not activate complement and leuckocytes fail to induce subepidermal blistering in mice. Br J Dermatol 2008;158:463-471. (Pubitemid 351239182)
6. Yu X, Holdorf K, Kasper B, Zillikens D, Ludwig RJ, Petersen F. FcgRIIA and FcgRIIIB Are required for autoantibodyinduced tissue damage in experimental human models of bullous pemphigoid. J Invest Dermatol 2010;30:2841-2844.
7. Kulkarni S, Sitaru C, Andersson KE, Damoulakis G, Davidson K, Hirose M, Juss J, OxleyD, Chessa TA, Ramadani F, Guillou H, Segonds-Pichon A, Fritsch A, Jarvis GE, Okkenhaug K, Ludwig R, Zillikens D, Mocsai A, Vanhaesebroeck B, Stephens LR, Hawkins PT. PI3Kb plays a critical role in neutrophil activation by immune complexes. Sci Signal 2011;4(168):ra23.
8. Recke A, Sitaru C, Vidarsson G, Evensen M, Chiriac MT, Ludwig RJ, Zillikens D. Pathogenicity of IgG subclass autoantibodies to type VII collagen: Induction of dermal-epidermal separation. J Autoimmun 2010;34:435-444.
9. Yamamoto T, Kihara I, Morita T, Oite T. Attachment of polymorphonuclear leukocytes to glomeruli with immune deposits. J Immunol Methods 1979;26:315-323.
10. Gammon WR, Merritt CC, Lewis DM, Sams WMJ, Wheeler CEJ, Carlo J. Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: Mechanism of cell attachment in the in vitro leukocyte attachment method. J Invest Dermatol 1981;76: 514-522. (Pubitemid 12239953)
11. Gammon WR, Inman AO, 3rd, Wheeler CE, Jr. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: Demonstration by leukocytic attachment and organ culture methods. J Invest Dermatol 1984;83:57-61. (Pubitemid 14080902)
12. Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Bröcker EB, Opdenakker G, Zillikens D, Sitaru C. Granulocytederived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 2004;204:519-527. (Pubitemid 39585950)
13. Liu Z, Zhao M, Li N, Diaz LA, Mayadas TN. Differential roles for beta2 integrins in experimental autoimmune bullous pemphigoid. Blood 2006;107:1063-1069. (Pubitemid 43156306)
14. Schön M, Ludwig RJ. Lymphocyte trafficking to inflames skin: Molecular mechanisms and implications for therapeutic target molecules. Expert Opin Ther Targets 2005;9:225-243. (Pubitemid 40613865)
15. Witebsky E. Concept of autoimmune disease. Ann N Y Acad Sci 1966;135:443-450.
16. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in mice by passive transfer of IgG from patients with the disease.NEngl J Med. 1993;306:1189-1196.
17. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993;92:2480-2488. (Pubitemid 23333558)
18. Roscoe JT, Diaz LA, Sampaio SAP, Castro RM, Labib RS, Takahashi Y, Patel H, Anhalt GJ. Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/C mice by passive transfer. J Invest Derm 1985;85:538-541. (Pubitemid 16204228)
19. Woodley DT, Chang C, Saadat P, Ram R, Liu Z, Chen M. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005;124:958-964. (Pubitemid 40629096)
20. WoodleyDT, Ram R, Doostan A, Bandyopadhyay P, Huang Y, Remington J, Hou Y, Keene DR, Liu Z, Chen M. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 2006;126: 1323-1330. (Pubitemid 43997915)
21. Chen M, Doostan A, Bandyopadhyay P, Remington J,Wang X, Hou Y, Liu Z. Woodley DT.The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol 2007;170:2009-2018. (Pubitemid 47339274)
22. Sitaru C, Chiriac MT, Mihai S, Büning J, Gebert A, Ishiko A, Zillikens D. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 2006;177:3461-3468. (Pubitemid 44277867)
23. Ludwig RJ, Recke A, Bieber K, Müller S, Marques Ade C, Banczyk D, Hirose M, Kasperkiewicz M, Ishii N, Schmidt E, Kasperkiewicz M, Ishii N, Schmidt E,Westermann J, Zillikens D, Ibrahim SM. Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. J Invest Dermatol 2011;131: 167-176.
24. Kasperkiewicz M, Hirose M, Recke A, Schmidt E, Zillikens D, Ludwig RJ. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita. Br J Dermatol 2010;162: 1064-1070.
25. Borradori L, Caldwell JB, Briggaman RA, Burr CE, Gammon WR, JamesWD, Yancey KB. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Arch Dermatol 1995;131:590-595.
26. Shigemoto T, Nashiro K, Tsuchida T, Seki Y, Tamaki K. Administration of IgG fraction of epidermolysis bullosa acquisita (EBA) serum into mice. J Dermatol 1988;15: 123-127.
27. Ludwig RJ, Zillikens D. Pathogenesis of epidermolysis bullosa acquisita. Dermatol Clin 2011;29:493-501.
28. Sitaru AG, Sesarman A, Mihai S, Chiriac MT, Zillikens D, Hultman P, Solbach W, Sitaru C. T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita. J Immunol 2010;184: 1596-1603.
29. Gross TL, Ihrke PJ, Walder EJ. Skin diseases of the dog and cat: Clinical and histopathologic diagnosis. Blackwell Pub Professional; 2005.
30. Olivry T, Fine JOD, Dunston SM, Chasse D, Tenorio AP, Monteiro-Riviere NA, Chen M, Woodley DT. Canine epidermolysis bullosa acquisita: Circulating autoantibodies target the aminoterminal non-collagenous (NC1) domain of collagen VII in anchoring fibrils. Vet Dermatol 1998;9:19-31. (Pubitemid 128560493)
31. Olivry T, Jackson HA. Diagnosing new autoimmune blistering skin diseases of dogs and cats. Clin Tech Small Anim Pract 2001;16:225-229.
32. Olivry T, Petersen A, Dunston SM, Chen M. Novel localised variant of canine epidermolysis bullosa acquisita. Vet Rec 2000;146:193-194. (Pubitemid 30102783)
33. Kuriya B, Arkema EV, Bykerk VP, Keystone EC. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: A metaanalysis of clinical and radiographic remission. Ann Rheum Dis 2010;69:1298-1304.
34. Schön MP, Boehncke WH. Psoriasis. N Engl JMed 2005;352: 1899-1912. (Pubitemid 40627816)
35. Ludwig RJ, Schmidt E. Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis? G Ital Dermatol Venereol 2009;144:339-349.